Skip to main content

OCREVUS ZUNOVO Financial Assistance Options

Genentech

OpenVerified·Mar 14, 2026

The OCREVUS Co-pay Program provides financial assistance for commercially insured patients to help cover the costs of OCREVUS or OCREVUS ZUNOVO medicine and its administration. Eligible patients (18+ years old, residing in the U.S. or U.S. Territories, not receiving government benefits) can receive up to $20,000 annually for drug costs and up to $1,500 annually for administration costs. This program explicitly does not cover travel, lodging, or other associated expenses beyond the medication and its administration.

Covers
financial assistance